Rutgers COVID-19 Cohort Study
- Conditions
- SARS-CoV-2Coronavirus
- Interventions
- Other: Non-Interventional
- First Posted Date
- 2020-04-07
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 829
- Registration Number
- NCT04336215
- Locations
- 🇺🇸
University Hospital, Newark, New Jersey, United States
🇺🇸Clinical Research Unit Rutgers New Jersey Medical School, Newark, New Jersey, United States
🇺🇸RUCDR Infinite Biologics, Piscataway, New Jersey, United States
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
- Conditions
- Recurrent Colon CarcinomaMetastatic Colorectal CarcinomaRefractory Colorectal CarcinomaStage IV Colon Cancer AJCC v7Stage IVA Colon Cancer AJCC v7Stage IVB Colon Cancer AJCC v7
- Interventions
- First Posted Date
- 2020-03-04
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 50
- Registration Number
- NCT04294264
- Locations
- 🇺🇸
Saint Barnabas Medical Center, Livingston, New Jersey, United States
🇺🇸RWJBarnabas Health - Monmouth Medical Center Southern Campus, Lakewood, New Jersey, United States
🇺🇸Trinitas Hospital and Comprehensive Cancer Center, Elizabeth, New Jersey, United States
Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Conditions
- Recurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRefractory Burkitt LymphomaHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Burkitt LymphomaRefractory Diffuse Large B-Cell LymphomaRefractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
- Interventions
- First Posted Date
- 2020-02-26
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Registration Number
- NCT04285268
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
- Conditions
- Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8Stage I Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8
- Interventions
- Radiation: High-Dose Rate BrachytherapyOther: Quality-of-Life AssessmentOther: Questionnaire AdministrationProcedure: Stereotactic Ablative Radiotherapy
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 10
- Registration Number
- NCT04253483
- Locations
- 🇺🇸
RWJBarnabas Health - Saint Barnabas Medical Center, Livingston, Livingston, New Jersey, United States
🇺🇸Rutgers New Jersey Medical School, Newark, New Jersey, United States
🇺🇸Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Yoga for Anxiety in Adults
- Conditions
- Parkinson DiseaseAnxiety
- Interventions
- Other: Tele-yoga
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 16
- Registration Number
- NCT04240899
- Locations
- 🇺🇸
Rutgers University, Newark, New Jersey, United States
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
- Conditions
- Essential TremorMovement DisordersHuntington DiseaseSpinocerebellar AtaxiasParkinson DiseaseDystonia, Primary
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 210
- Registration Number
- NCT04231487
- Locations
- 🇺🇸
Rutgers University, Newark, New Jersey, United States
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
- Conditions
- Plasma Cell Myeloma
- Interventions
- First Posted Date
- 2019-12-26
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 70
- Registration Number
- NCT04211259
- Locations
- 🇺🇸
RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick, New Jersey, United States
🇺🇸Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Development and Testing of a Mobile Health Application for Management of Gestational Diabetes
- Conditions
- Diabetes, GestationalTelemedicine
- Interventions
- Behavioral: Develop a mobile app that supports self- management and treatment for Nepalese GDM patients
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 220
- Registration Number
- NCT04198857
- Locations
- 🇳🇵
Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Kavrepalanchok, Nepal
Sugar-Sweetened Beverage Portion Limit Study
- Conditions
- Health Policy
- Interventions
- Behavioral: Sweetened beverage portion size limit
- First Posted Date
- 2019-12-12
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 359
- Registration Number
- NCT04197063
Focus Group in Collecting Feedbacks From Indoor Tanning Bed Users for Social Media-Delivered Intervention Development
- Conditions
- Health Status Unknown
- Interventions
- Other: Questionnaire AdministrationOther: Survey Administration
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 20
- Registration Number
- NCT04179227
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States